Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and a-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and a-tocopherol equivalents are administered in a daily amount of 50-400 mg.

Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and ?-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and ?-tocopherol equivalents are administered in a daily amount of 50-400 mg.

Abstract: A nutritional booster composition suitable for the treatment of pressure ulcers, comprising proteins, carbohydrates and fats and, in a daily unit dose: 3-15 g of arginine or equivalents thereof, 180-840 mg of ascorbic acid equivalents, 50-400 mg of ?-tocopherol equivalents, and 8-40 mg of flavonoids.

Abstract: A nutritional composition, suitable for enteral administration, is described which contains 5-120 g of composite dietary fibre per daily dosage of the composition or per 2000 kcal, which fibre consists of 15-50 wt. % of soluble non-starch polysaccharides, such as gum arabic or pectin, 15-45 wt. % of insoluble non-starch polysaccharides, such as cellulose and hemicellulose, and 8-70 wt. % of oligosaccharides and/or resistant starch and/or lignin. The oligosaccharides such as inulin or hydrolyzed inulin can be present at a level of 8-40 wt. %. The resistant starch may be present at a level of 5-30 wt. %. The composition may further contain carbohydrates and/or fats and/or proteinaceous material and may be dry or liquid. It may be used as a complete food or a food supplement, e.g. for clinical patients or infants.